Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
"The Norwegian Adult Mental Health Registry" (NAMHR) is a medical quality register collecting and systematizing data on patients and their treatment in specialist mental health care for adults in Norway. The main purpose is to create a documentation basis for quality assurance, evaluation, and improvement of assessment and treatment for patients who are offered treatment for mental disorders in the specialist health service. The register uses automatic data capture from various existing data sources. New patients are automatically included, but given the opportunity for reservations from the register without affecting their services and treatment.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Patient Reported Outcome Measures (PROMs) | Percentage of subjects that experienced change in PROMs | Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months |
| Patient Reported Outcome Measures (PROMs) | Percentage of subjects that experienced change in PROMs | Discharge defined as: date of discharge from any cause, assessed up to 60 months |
| Patient Reported Outcome Measures (PROMs) | Percentage of subjects that experienced change in PROMs | Six months after discharge |
| Drug name and dosage from electronic medication management solutions | Frequency of psychotropic generic drug name and dosage | Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months |
| Drug name and dosage from electronic medication management solutions | Frequency of psychotropic generic drug name and dosage | Discharge defined as: date of discharge from any cause, assessed up to 60 months |
| Drug name and dosage from electronic medication management solutions | Frequency of psychotropic generic drug name and dosage | Six months after discharge from any cause, assessed up to 12 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Residents in Norway aged 18 years or older and granted right to treatment in mental specialized in- and out-patient settings (approximately 150.000 participants)
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Inge Joa, PhD | Contact | +4791392373 | inge.joa@sus.no | |
| Tore Tjora, PhD | Contact | tore.tjora@sus.no |
| Name | Affiliation | Role |
|---|---|---|
| Inge Joa, PhD | Stavanger University hospital, Stavanger, Norway | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D003863 | Depression |
| D012559 | Schizophrenia |
| D001714 | Bipolar Disorder |
| D001068 | Feeding and Eating Disorders |
| D001008 | Anxiety Disorders |
| D013313 | Stress Disorders, Post-Traumatic |
| D010554 | Personality Disorders |
| D001289 | Attention Deficit Disorder with Hyperactivity |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D019967 | Schizophrenia Spectrum and Other Psychotic Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
| Rate of overweight defined as BMI > 25 (body mass index) | Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. | Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months |
| Rate of overweight defined as BMI > 25 (body mass index) | Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. | Discharge defined as: date of discharge from any cause, assessed up to 60 months |
| Level of glycated haemoglobin (HbA1c) | Glycated hemoglobin is a form of hemoglobin chemically linked to sugar. | Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months |
| Level of glycated haemoglobin (HbA1c) | Glycated hemoglobin is a form of hemoglobin chemically linked to sugar. | Discharge defined as: date of discharge from any cause, assessed up to 60 months |
| Level of blood pressure, both systolic and diastolic levels | Blood pressure varies between systolic and diastolic pressures after each heartbeat. Systolic pressure is peak (maximum) pressure in the arteries. Diastolic pressure is the lowest (minimum) pressure in the arteries. | Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months |
| Level of blood pressure, both systolic and diastolic levels | Blood pressure varies between systolic and diastolic pressures after each heartbeat. Systolic pressure is peak (maximum) pressure in the arteries. Diastolic pressure is the lowest (minimum) pressure in the arteries. | Discharge defined as: date of discharge from any cause, assessed up to 60 months |
| Bloodlevels of total cholesterol, LDL, HDL and Triglycerides | A lipid profile (lipid panel) is a set blood tests used to find abnormalities in blood lipids. The present panel will include: total cholesterol, LDL, HDL and Triglycerides. | Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months |
| Bloodlevels of total cholesterol, LDL, HDL and Triglycerides | A lipid profile (lipid panel) is a set blood tests used to find abnormalities in blood lipids. The present panel will include: total cholesterol, LDL, HDL and Triglycerides. | Discharge defined as: date of discharge from any cause, assessed up to 60 months |
| Frequency of ICD-10 or ICD-11 diagnosis F00-F99 | International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) or ISD-11: Chapter V: Mental and behavioural disorders (F00-F99) | Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months |
| Frequency of ICD-10 or ICD-11 diagnosis F00-F99 | International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) or ISD-11: Chapter V: Mental and behavioural disorders (F00-F99)Revision (ICD-10) WHO: Chapter V: Mental and behavioural disorders (F00-F99) | Discharge defined as: date of discharge from any cause, assessed up to 60 months |
| D000068105 | Bipolar and Related Disorders |
| D019964 | Mood Disorders |
| D012817 | Signs and Symptoms, Digestive |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D040921 | Stress Disorders, Traumatic |
| D000068099 | Trauma and Stressor Related Disorders |
| D019958 | Attention Deficit and Disruptive Behavior Disorders |
| D065886 | Neurodevelopmental Disorders |